Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids

Identifieur interne : 002736 ( Main/Exploration ); précédent : 002735; suivant : 002737

Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids

Auteurs : Colin W. Pouton [Royaume-Uni] ; Paul Lucas [Royaume-Uni] ; Beverley J. Thomas [Royaume-Uni] ; Aimalohi N. Uduehi [Royaume-Uni] ; David A. Milroy [Royaume-Uni] ; Stephen H. Moss [Royaume-Uni]

Source :

RBID : ISTEX:8BE198C56DD008FF8498C7BD3DEFC52625BDAD13

Descripteurs français

English descriptors

Abstract

Abstract: DNA plasmids formed particulate complexes with a variety of cationic polyamino acids and cationic lipids, which were used to transfect mammalian cells in culture. Complexation was studied by assaying for exclusion of ethidium using a fluorometric assay, which indicated that complexation with cationic polyamino acids took place with utilisation of the majority of charged functional groups. The particle sizes and zeta potentials of a range of complexes were determined. Generally polyamino acids formed uniform particles 80–120 nm in diameter in water, but their particle size increased on dilution of the particles in electrolytes or cell culture media. The efficiency of transfection was compared using complexes of pRSVlacZ, a reporter construct which expressed β-galactosidase under the control of the Rous sarcoma virus promoter. Positively charged DNA/polyamino acid complexes were taken up by cells but required an endosomolytic agent, such as chloroquine, to facilitate transfection. Polyornithine complexes resulted in the highest levels of expression, in comparison with other homopolyamino acids (polyornithine>poly-l-lysine=poly-d-lysine>polyarginine). Copolyamino acids of lysine and alanine condensed DNA but were less active in transfection experiments. Copoly(l-Lys, l-Ala 1:1) was inactive even in the presence of chloroquine. In contrast DNA/cationic lipid complexes transfected cells spontaneously, and chloroquine did not improve the extent of expression, rather it usually reduced efficiency. There was little correlation between comparative efficiencies of lipid complexes between cell lines suggesting that the nature of the cell membrane and differences in mechanisms of internalisation were determinants of efficiency. In an effort to explore better cell culture models for gene delivery, monolayers of Caco-2 cells were transfected in filter culture. As the cells differentiated and formed a polarized monolayer, expression of β-galactosidase was reduced until at day 27 expression was not significantly different from basal activity. The Caco-2 filter culture model merits further attention as a model of gene delivery to epithelial surfaces, such as would be encountered in the lung after inhalation.

Url:
DOI: 10.1016/S0168-3659(98)00015-7


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids</title>
<author>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W" last="Pouton">Colin W. Pouton</name>
</author>
<author>
<name sortKey="Lucas, Paul" sort="Lucas, Paul" uniqKey="Lucas P" first="Paul" last="Lucas">Paul Lucas</name>
</author>
<author>
<name sortKey="Thomas, Beverley J" sort="Thomas, Beverley J" uniqKey="Thomas B" first="Beverley J" last="Thomas">Beverley J. Thomas</name>
</author>
<author>
<name sortKey="Uduehi, Aimalohi N" sort="Uduehi, Aimalohi N" uniqKey="Uduehi A" first="Aimalohi N" last="Uduehi">Aimalohi N. Uduehi</name>
</author>
<author>
<name sortKey="Milroy, David A" sort="Milroy, David A" uniqKey="Milroy D" first="David A" last="Milroy">David A. Milroy</name>
</author>
<author>
<name sortKey="Moss, Stephen H" sort="Moss, Stephen H" uniqKey="Moss S" first="Stephen H" last="Moss">Stephen H. Moss</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8BE198C56DD008FF8498C7BD3DEFC52625BDAD13</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1016/S0168-3659(98)00015-7</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-38LZC4R8-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000A48</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A48</idno>
<idno type="wicri:Area/Istex/Curation">000A48</idno>
<idno type="wicri:Area/Istex/Checkpoint">001540</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001540</idno>
<idno type="wicri:doubleKey">0168-3659:1998:Pouton C:polycation:dna:complexes</idno>
<idno type="wicri:Area/Main/Merge">002778</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:98-0366945</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000079</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000091</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000074</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000074</idno>
<idno type="wicri:doubleKey">0168-3659:1998:Pouton C:polycation:dna:complexes</idno>
<idno type="wicri:Area/Main/Merge">002888</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9741937</idno>
<idno type="wicri:Area/PubMed/Corpus">000495</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000495</idno>
<idno type="wicri:Area/PubMed/Curation">000495</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000495</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000473</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000473</idno>
<idno type="wicri:Area/Ncbi/Merge">001186</idno>
<idno type="wicri:Area/Ncbi/Curation">001186</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001186</idno>
<idno type="wicri:doubleKey">0168-3659:1998:Pouton C:polycation:dna:complexes</idno>
<idno type="wicri:Area/Main/Merge">002756</idno>
<idno type="wicri:Area/Main/Curation">002736</idno>
<idno type="wicri:Area/Main/Exploration">002736</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids</title>
<author>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W" last="Pouton">Colin W. Pouton</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lucas, Paul" sort="Lucas, Paul" uniqKey="Lucas P" first="Paul" last="Lucas">Paul Lucas</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Beverley J" sort="Thomas, Beverley J" uniqKey="Thomas B" first="Beverley J" last="Thomas">Beverley J. Thomas</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Uduehi, Aimalohi N" sort="Uduehi, Aimalohi N" uniqKey="Uduehi A" first="Aimalohi N" last="Uduehi">Aimalohi N. Uduehi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Milroy, David A" sort="Milroy, David A" uniqKey="Milroy D" first="David A" last="Milroy">David A. Milroy</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Moss, Stephen H" sort="Moss, Stephen H" uniqKey="Moss S" first="Stephen H" last="Moss">Stephen H. Moss</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Controlled Release</title>
<title level="j" type="abbrev">COREL</title>
<idno type="ISSN">0168-3659</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">53</biblScope>
<biblScope unit="issue">1–3</biblScope>
<biblScope unit="page" from="289">289</biblScope>
<biblScope unit="page" to="299">299</biblScope>
</imprint>
<idno type="ISSN">0168-3659</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0168-3659</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Active ingredient</term>
<term>Animals</term>
<term>COS Cells</term>
<term>Cell Line, Transformed</term>
<term>Complexation</term>
<term>DNA</term>
<term>DNA (administration & dosage)</term>
<term>DNA (chemistry)</term>
<term>Established cell line</term>
<term>Gene expression</term>
<term>Gene therapy</term>
<term>Genetic Therapy</term>
<term>Genetic transfer</term>
<term>Human</term>
<term>Humans</term>
<term>In vitro</term>
<term>Lipids</term>
<term>Lipids (administration & dosage)</term>
<term>Lipids (chemistry)</term>
<term>Lipids (pharmacology)</term>
<term>Lysine polymer</term>
<term>Mice</term>
<term>Peptides (administration & dosage)</term>
<term>Peptides (pharmacology)</term>
<term>Pharmaceutical technology</term>
<term>Plasmids</term>
<term>Polyamines (chemistry)</term>
<term>Polycation</term>
<term>Release</term>
<term>Transfection</term>
<term>Treatment</term>
<term>Tumor Cells, Cultured</term>
<term>Tumor cell</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ADN ()</term>
<term>ADN (administration et posologie)</term>
<term>Animaux</term>
<term>Cellules COS</term>
<term>Cellules cancéreuses en culture</term>
<term>Humains</term>
<term>Lignée de cellules transformées</term>
<term>Lipides ()</term>
<term>Lipides (administration et posologie)</term>
<term>Lipides (pharmacologie)</term>
<term>Peptides (administration et posologie)</term>
<term>Peptides (pharmacologie)</term>
<term>Plasmides</term>
<term>Polyamines ()</term>
<term>Souris</term>
<term>Thérapie génétique</term>
<term>Transfection</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>DNA</term>
<term>Lipids</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>DNA</term>
<term>Lipids</term>
<term>Polyamines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Lipids</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>ADN</term>
<term>Lipides</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Lipides</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>COS Cells</term>
<term>Cell Line, Transformed</term>
<term>Genetic Therapy</term>
<term>Humans</term>
<term>Mice</term>
<term>Plasmids</term>
<term>Transfection</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>ADN</term>
<term>Animaux</term>
<term>Cellule tumorale</term>
<term>Cellules COS</term>
<term>Cellules cancéreuses en culture</term>
<term>Complexation</term>
<term>DNA</term>
<term>Expression génique</term>
<term>Homme</term>
<term>Humains</term>
<term>In vitro</term>
<term>Libération</term>
<term>Lignée CACO2</term>
<term>Lignée cellulaire établie</term>
<term>Lignée de cellules transformées</term>
<term>Lipide</term>
<term>Lipides</term>
<term>Lysine polymère</term>
<term>Plasmides</term>
<term>Polyamines</term>
<term>Polycation</term>
<term>Principe actif</term>
<term>Souris</term>
<term>Technologie pharmaceutique</term>
<term>Thérapie génique</term>
<term>Thérapie génétique</term>
<term>Traitement</term>
<term>Transfection</term>
<term>Transfert génétique</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Absorbance readings</term>
<term>Better cell culture models</term>
<term>Cationic</term>
<term>Cationic lipid</term>
<term>Cationic lipids</term>
<term>Cationic liposomes</term>
<term>Cationic polyamino acids</term>
<term>Cationic polypeptides</term>
<term>Cell culture</term>
<term>Cell culture models</term>
<term>Cell extracts</term>
<term>Cell lines</term>
<term>Charge ratio</term>
<term>Charge ratios</term>
<term>Chloroquine</term>
<term>Colon carcinoma</term>
<term>Complex formation</term>
<term>Complexation</term>
<term>Complexed</term>
<term>Control levels</term>
<term>Data standardised</term>
<term>Direct gene transfer</term>
<term>Dotap</term>
<term>Endosomolytic agent</term>
<term>Enzyme activity</term>
<term>Ethidium</term>
<term>Ethidium exclusion</term>
<term>Fresh chloroquine</term>
<term>Gene</term>
<term>Gene delivery</term>
<term>Gene delivery systems</term>
<term>Gene expression</term>
<term>Gene therapy</term>
<term>Gene transfer</term>
<term>Lipid</term>
<term>Liposome</term>
<term>Little correlation</term>
<term>Malvern instruments</term>
<term>Mammalian cells</term>
<term>Mass ratio</term>
<term>Murine melanoma cells</term>
<term>Nonviral gene therapy</term>
<term>Optimum charge ratio</term>
<term>Particle size</term>
<term>Pharmaceutical scientists</term>
<term>Physical properties</term>
<term>Plasmid</term>
<term>Polyamino</term>
<term>Polyamino acids</term>
<term>Polycationic polymers</term>
<term>Polylysine</term>
<term>Polyornithine complexes</term>
<term>Pouton</term>
<term>Power spectra</term>
<term>Protein content</term>
<term>Prsvlacz</term>
<term>Prsvlacz complexed</term>
<term>Relative activities</term>
<term>Reporter gene</term>
<term>Room temperature</term>
<term>Standard curve</term>
<term>Sterile water</term>
<term>Total charge ratio</term>
<term>Transfect cells</term>
<term>Transfected</term>
<term>Transfection</term>
<term>Transfection medium</term>
<term>Zeta</term>
<term>Zeta potentials</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: DNA plasmids formed particulate complexes with a variety of cationic polyamino acids and cationic lipids, which were used to transfect mammalian cells in culture. Complexation was studied by assaying for exclusion of ethidium using a fluorometric assay, which indicated that complexation with cationic polyamino acids took place with utilisation of the majority of charged functional groups. The particle sizes and zeta potentials of a range of complexes were determined. Generally polyamino acids formed uniform particles 80–120 nm in diameter in water, but their particle size increased on dilution of the particles in electrolytes or cell culture media. The efficiency of transfection was compared using complexes of pRSVlacZ, a reporter construct which expressed β-galactosidase under the control of the Rous sarcoma virus promoter. Positively charged DNA/polyamino acid complexes were taken up by cells but required an endosomolytic agent, such as chloroquine, to facilitate transfection. Polyornithine complexes resulted in the highest levels of expression, in comparison with other homopolyamino acids (polyornithine>poly-l-lysine=poly-d-lysine>polyarginine). Copolyamino acids of lysine and alanine condensed DNA but were less active in transfection experiments. Copoly(l-Lys, l-Ala 1:1) was inactive even in the presence of chloroquine. In contrast DNA/cationic lipid complexes transfected cells spontaneously, and chloroquine did not improve the extent of expression, rather it usually reduced efficiency. There was little correlation between comparative efficiencies of lipid complexes between cell lines suggesting that the nature of the cell membrane and differences in mechanisms of internalisation were determinants of efficiency. In an effort to explore better cell culture models for gene delivery, monolayers of Caco-2 cells were transfected in filter culture. As the cells differentiated and formed a polarized monolayer, expression of β-galactosidase was reduced until at day 27 expression was not significantly different from basal activity. The Caco-2 filter culture model merits further attention as a model of gene delivery to epithelial surfaces, such as would be encountered in the lung after inhalation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W" last="Pouton">Colin W. Pouton</name>
</noRegion>
<name sortKey="Lucas, Paul" sort="Lucas, Paul" uniqKey="Lucas P" first="Paul" last="Lucas">Paul Lucas</name>
<name sortKey="Milroy, David A" sort="Milroy, David A" uniqKey="Milroy D" first="David A" last="Milroy">David A. Milroy</name>
<name sortKey="Moss, Stephen H" sort="Moss, Stephen H" uniqKey="Moss S" first="Stephen H" last="Moss">Stephen H. Moss</name>
<name sortKey="Thomas, Beverley J" sort="Thomas, Beverley J" uniqKey="Thomas B" first="Beverley J" last="Thomas">Beverley J. Thomas</name>
<name sortKey="Uduehi, Aimalohi N" sort="Uduehi, Aimalohi N" uniqKey="Uduehi A" first="Aimalohi N" last="Uduehi">Aimalohi N. Uduehi</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002736 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002736 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:8BE198C56DD008FF8498C7BD3DEFC52625BDAD13
   |texte=   Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021